یوسف مرتضوی - Dept of Molecular Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
سحر طاهری - Faculty of Medicine, Zanjan, Iran
جلال درخشنده - Dept of Ophthalmology, Vali-e-Asr Hospital, Zanjan, Iran
سیروس زینلی - Dept of Molecular Medicine, Pasteur Institute of Iran, Tehran, Iran

Background and Objective: B-thalassemia is an autosomal recessive disease characterized by reduction or complete absence of b-globin gene expression. It has been estimated that more than ۲,۰۰۰,۰۰۰ carriers as well as ۲۰,۰۰۰ patients affected with b-thalassemia are living in Iran, a country with more than ۷۰ million population and great ethnic diversity. In this study we aimed to find out the b-globin gene frequency and determine the spectrum of b-globin gene mutations in Zanjan province (northwest region) of Iran. Materials and Methods: ۵۵۲۷ individuals who were referred for pre-marriage tests to Zanjan clinic as well as ۲۷ thalassemia patients were studied. Altogether one hundred and five chromosomes from ۷۸ unrelated B-thalassemia patients or carriers were examined for b-globin gene mutations by ARMS-PCR and direct gene sequencing. Based on the previous information on common mutations in Mediterranean populations ۲۴ sites were analyzed. Results: It was found that the b-thalassemia frequency is ۱.۲% for Zanjan region. Using the above techniques, the mutations for ۹۰/۱۰۵ (۸۶.۷ %) of b-thalassemia chromosomes (۱۳ different mutations) were identified. Fifty eight percent of the mutations were of common “Mediterranean” type. Of which, IVS-I ۱۱۰ mutation showed the highest frequency (۲۹.۵%) followed by IVS-II-۱ (۱۳.۳%), IVS-I-۱ (۱۲.۴%) and IVS-I-۶ (۲.۹%). ۱۰.۵% of mutations were of common Asian Indian mutations (Fr ۸/۹, ۶.۷% and IVS-I-۵, ۳.۸%) respectively. CD۵ and CD۳۰ and CD۳۶-۳۷ mutations accounted for ۱۳.۳% of the mutations. (۵.۷%, ۰.۹۵% and ۶.۷% respectively) Mutations in ۱۴ chromosomes (۱۳.۳%) remained uncharacterized. Conclusion: These data suggests that the spectrum of mutations in Zanjan province differs from those reported from other parts of Iran, but Mediterranean type of mutations are more frequent in Zanjan region. Therefore, in order to save the time and cost, it is recommended that for prenatal diagnosis of thalassemia in Zanjan province analysis of Mediterranean mutations should be considered as a front line screening strategy.

Keywords: B-thalassemia, Mutation, Zanjan, ARMS-PCR